Transforming growth factor–β1 gene transfer ameliorates acute lung allograft rejection
- 1 May 2000
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 119 (5) , 913-920
- https://doi.org/10.1016/s0022-5223(00)70086-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allograftsThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Ex vivo liposome-mediated gene transfer to lung isograftsThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Liposome-mediated gene transfer to lung isograftsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.Journal of Clinical Investigation, 1997
- Gene therapy and allotransplantationCurrent Opinion in Immunology, 1997
- Ex Vivo Adenoviral-Mediated Gene Transfer to Lung Isografts During Cold PreservationThe Annals of Thoracic Surgery, 1997
- Gene therapy in transplantationTransplant Immunology, 1996
- Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes.Proceedings of the National Academy of Sciences, 1995
- Transduction of Hepatic Allografts Achieves Local Levels of Viral IL-10 Which Suppress Alloreactivity in VitroJournal of Surgical Research, 1995
- Gene Transfer for Transplantation Prolongation of Allograft Survival with Transforming Growth Factor-β1Annals of Surgery, 1994